Sivik Global Healthcare’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.9M | Buy |
100,000
+30,000
| +43% | +$2.07M | 1.88% | 14 |
|
|
2025
Q1 | $4.86M | Hold |
70,000
| – | – | 2.63% | 21 |
|
|
2024
Q4 | $6.02M | Sell |
70,000
-20,000
| -22% | -$1.72M | 3.17% | 9 |
|
|
2024
Q3 | $10.7M | Hold |
90,000
| – | – | 4.54% | 4 |
|
|
2024
Q2 | $12.8M | Sell |
90,000
-2,500
| -3% | -$357K | 4.61% | 2 |
|
|
2024
Q1 | $11.9M | Buy |
92,500
+2,500
| +3% | +$321K | 2.78% | 3 |
|
|
2023
Q4 | $9.31M | Hold |
90,000
| – | – | 3.89% | 5 |
|
|
2023
Q3 | $8.19M | Sell |
90,000
-10,000
| -10% | -$909K | 4.14% | 5 |
|
|
2023
Q2 | $8.09M | Sell |
100,000
-20,000
| -17% | -$1.62M | 1.89% | 6 |
|
|
2023
Q1 | $9.55M | Buy |
120,000
+20,000
| +20% | +$1.59M | 4.1% | 3 |
|
|
2022
Q4 | $6.77M | Buy |
100,000
+20,000
| +25% | +$1.35M | 3.18% | 10 |
|
|
2022
Q3 | $3.99M | Sell |
80,000
-40,000
| -33% | -$1.99M | 2.21% | 24 |
|
|
2022
Q2 | $6.69M | Buy |
120,000
+30,000
| +33% | +$1.67M | 3.8% | 8 |
|
|
2022
Q1 | $5M | Buy |
+90,000
| New | +$5M | 2.06% | 24 |
|
|
2020
Q3 | – | Sell |
-420,000
| Closed | -$7.37M | – | 55 |
|
|
2020
Q2 | $7.37M | Sell |
420,000
-80,000
| -16% | -$1.4M | 2.44% | 17 |
|
|
2020
Q1 | $8.16M | Buy |
+500,000
| New | +$8.16M | 3.22% | 11 |
|
|
2019
Q2 | – | Sell |
-270,000
| Closed | -$7.06M | – | 64 |
|
|
2019
Q1 | $7.06M | Buy |
+270,000
| New | +$7.06M | 2.6% | 12 |
|
|
2018
Q3 | – | Sell |
-100,000
| Closed | -$2.31M | – | 64 |
|
|
2018
Q2 | $2.31M | Buy |
+100,000
| New | +$2.31M | 0.89% | 46 |
|
|
2018
Q1 | – | Sell |
-100,000
| Closed | -$2.68M | – | 64 |
|
|
2017
Q4 | $2.68M | Buy |
+100,000
| New | +$2.68M | 1% | 49 |
|